Christoph Justinger1, Konstantinos Kouladouros1, Daniel Gärtner1, Klaus Tatsch2, Peter Reimer3, Thomas Rüdiger4, Martin Binnenhei5, Martin Bentz5, Michael R Schön1. 1. Department of General and Visceral Surgery, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany. 2. Department of Nuclear Medicine, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany. 3. Department of Diagnostic and Interventional Radiology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany. 4. Department of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany. 5. Department of Oncology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Abstract
BACKGROUND AND OBJECTIVES: Extent of liver resections are restricted by the volume of the future liver remnant. Different strategies have been developed to increase the frequency of curative resections. Selective internal radiation therapy (SIRT) has emerged as an effective therapy for patients with primary non-resectable malignancies of the liver. Here, we report the first clinical series of patients with curative liver resection following SIRT. METHODS: Starting 2010, patients with marginally resectable liver metastases treated by SIRT followed by liver resection were identified and prospectively documented in a database for subsequent retrospective analysis. RESULTS: Thirteen patients (five female, eight male; age 70 years [32-77 years]) with marginally resectable liver metastases were selected for liver resection after SIRT. After performing SIRT, 12 patients had potentially curative hepatic resection. In two patients, liver resection after SIRT could not be performed due to the appearance of new extrahepatic metastases. Analyzing the effect of SIRT, we observed a decrease in tumor size with central scaring. None of the patients developed liver necrosis after SIRT. Liver resection was performed safely in all patients. CONCLUSIONS: The combination of SIRT with state-of-the-art liver surgery opens up new therapeutic options in patients with liver metastases.
BACKGROUND AND OBJECTIVES: Extent of liver resections are restricted by the volume of the future liver remnant. Different strategies have been developed to increase the frequency of curative resections. Selective internal radiation therapy (SIRT) has emerged as an effective therapy for patients with primary non-resectable malignancies of the liver. Here, we report the first clinical series of patients with curative liver resection following SIRT. METHODS: Starting 2010, patients with marginally resectable liver metastases treated by SIRT followed by liver resection were identified and prospectively documented in a database for subsequent retrospective analysis. RESULTS: Thirteen patients (five female, eight male; age 70 years [32-77 years]) with marginally resectable liver metastases were selected for liver resection after SIRT. After performing SIRT, 12 patients had potentially curative hepatic resection. In two patients, liver resection after SIRT could not be performed due to the appearance of new extrahepatic metastases. Analyzing the effect of SIRT, we observed a decrease in tumor size with central scaring. None of the patients developed liver necrosis after SIRT. Liver resection was performed safely in all patients. CONCLUSIONS: The combination of SIRT with state-of-the-art liver surgery opens up new therapeutic options in patients with liver metastases.
Authors: Christopher Noda; Gregory A Williams; Gretchen Foltz; Hyun Kim; Dominic E Sanford; Chet W Hammill; Ryan C Fields Journal: J Surg Oncol Date: 2020-07-13 Impact factor: 2.885
Authors: Michael Vouche; Thierry Degrez; Fikri Bouazza; Philippe Delatte; Maria Gomez Galdon; Alain Hendlisz; Patrick Flamen; Vincent Donckier Journal: World J Hepatol Date: 2017-12-28
Authors: Helen Winter; Joseph Rassam; Pradeep S Virdee; Rob Goldin; Priyankaa Pitcheshwar; Klara Weaver; John Primrose; David P Berry; Harpreet S Wasan; Ricky A Sharma Journal: Cancers (Basel) Date: 2019-08-12 Impact factor: 6.639
Authors: Emrullah Birgin; Erik Rasbach; Steffen Seyfried; Nils Rathmann; Steffen J Diehl; Stefan O Schoenberg; Christoph Reissfelder; Nuh N Rahbari Journal: Cancers (Basel) Date: 2020-01-27 Impact factor: 6.639
Authors: Sebastian Mafeld; Peter Littler; Hannah Hayhurst; Derek Manas; Ralph Jackson; John Moir; Jeremy French Journal: J Gastrointest Cancer Date: 2020-03
Authors: Daniel Aliseda; Pablo Martí-Cruchaga; Gabriel Zozaya; Alberto Benito; Luis Lopez-Olaondo; Macarena Rodríguez-Fraile; José I Bilbao; Francisco Hidalgo; Mercedes Iñarrairaegui; Rubén Ciria; Fernando Pardo; Bruno Sangro; Fernando Rotellar Journal: Langenbecks Arch Surg Date: 2022-02-28 Impact factor: 2.895